- Report
- February 2024
- 111 Pages
Global
From €4588EUR$4,750USD£3,926GBP
- Report
- April 2024
- 175 Pages
From €4829EUR$5,000USD£4,132GBP
- Report
- July 2020
- 142 Pages
North America
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- July 2020
- 143 Pages
Europe
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- July 2020
- 142 Pages
Asia Pacific
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- May 2020
- 198 Pages
Global
From €3076EUR$3,185USD£2,632GBP
€4394EUR$4,550USD£3,761GBP
The Digital Genome market is a subset of the larger Genomics market, which focuses on the study of the structure, function, evolution, and mapping of genomes. Digital Genome technology is used to analyze and interpret genomic data, enabling researchers to gain insights into the genetic basis of diseases and other biological processes. This technology is used to develop new diagnostics, treatments, and therapies, as well as to improve existing ones.
Digital Genome technology is also used to identify and characterize genetic variants, which can be used to identify individuals at risk of certain diseases or to predict drug responses. Additionally, Digital Genome technology can be used to identify and characterize microbial communities, which can be used to improve agricultural productivity and food safety.
Companies in the Digital Genome market include Illumina, Thermo Fisher Scientific, BGI, Genomics plc, and Pacific Biosciences. Show Less Read more